Poseida Therapeutics, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.42 | -$0.42 | -$0.42 |
Q2 2024 | 0 | -$0.41 | -$0.41 | -$0.41 |
Q3 2024 | 3 | -$0.48 | -$0.33 | -$0.42 |
Q4 2024 | 0 | -$0.42 | -$0.42 | -$0.42 |
Q1 2025 | 2 | -$0.47 | -$0.47 | -$0.47 |
Q2 2025 | 2 | -$0.54 | -$0.54 | -$0.54 |
Q3 2025 | 2 | -$0.53 | -$0.53 | -$0.53 |
Q4 2025 | 2 | -$0.43 | -$0.43 | -$0.43 |
Q1 2026 | 0 | -$0.26 | -$0.26 | -$0.26 |
Q2 2026 | 0 | -$0.27 | -$0.27 | -$0.27 |
Q3 2026 | 0 | -$0.27 | -$0.27 | -$0.27 |
Q4 2026 | 0 | -$0.28 | -$0.28 | -$0.28 |
Poseida Therapeutics, Inc. Earnings Date And Information
Poseida Therapeutics, Inc. last posted its earnings results on Monday, August 5th, 2024. The company reported $-0.32 earnings per share for the quarter, topping analysts' consensus estimates of $-0.43 by $0.11. The company had revenue of 25.97 M for the quarter and had revenue of 64.70 M for the year. Poseida Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.37 diluted earnings per share) and currently has a price-to-earnings ratio of -2.32. Poseida Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Poseida Therapeutics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/05/2024 | Q2 2024 | -$0.43 | -$0.32 | 0.11 | $15.42 M | $25.97 M |
05/14/2024 | Q1 2024 | -$0.43 | -$0.25 | 0.18 | $28.14 M | |
03/07/2024 | Q4 2023 | -$0.36 | -$0.27 | 0.09 | $25.00 M | |
11/09/2023 | Q3 2023 | -$0.29 | -$0.35 | -0.06 | $18.87 M | $9.35 M |
08/08/2023 | Q2 2023 | -$0.53 | -$0.32 | 0.21 | $6.78 M | $20.01 M |
05/09/2023 | Q1 2023 | -$0.40 | -$0.47 | -0.07 | $10.34 M | |
03/09/2023 | Q4 2022 | $0.47 | -$0.39 | -0.86 | $9.92 M | |
11/10/2022 | Q3 2022 | -$0.65 | $0.92 | 1.57 | $1.25 M | $116.31 M |
08/11/2022 | Q2 2022 | -$0.84 | -$0.71 | 0.13 | $2.70 M | |
05/12/2022 | Q1 2022 | -$0.58 | -$0.95 | -0.37 | $1.44 M | |
03/10/2022 | Q4 2021 | -$0.35 | $0.02 | 0.37 | $23.13 M | $31,238 |
11/09/2021 | Q3 2021 | -$0.75 | -$0.68 | 0.07 | $0 | |
08/12/2021 | Q2 2021 | -$0.64 | -$0.74 | -0.1 | $0 | |
05/11/2021 | Q1 2021 | -$0.67 | -$0.62 | 0.05 | $0 | |
03/11/2021 | Q4 2020 | -$0.69 | -$0.00 | 0.69 | $0 | |
11/12/2020 | Q3 2020 | -$0.55 | -$0.63 | -0.08 | $0 | |
08/20/2020 | Q2 2020 | -$0.53 | $3.63 M | $0 | ||
03/30/2020 | Q1 2020 | -$0.50 | $0 | |||
12/30/2019 | Q4 2019 | -$0.59 | $0 | |||
09/29/2019 | Q3 2019 | -$0.53 | $0 |
Poseida Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Poseida Therapeutics, Inc.'s earnings date?
Poseida Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
Did Poseida Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Poseida Therapeutics, Inc. (:PSTX) reported $-0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.43 by $0.11.
-
How can I listen to Poseida Therapeutics, Inc.'s earnings conference call?
The conference call for Poseida Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Poseida Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Poseida Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Poseida Therapeutics, Inc. generate each year?
Poseida Therapeutics, Inc. (:PSTX) has a recorded annual revenue of $64.70 M.
-
How much profit does Poseida Therapeutics, Inc. generate each year?
Poseida Therapeutics, Inc. (:PSTX) has a recorded net income of $64.70 M. Poseida Therapeutics, Inc. has generated $-1.37 earnings per share over the last four quarters.
-
What is Poseida Therapeutics, Inc.'s price-to-earnings ratio?
Poseida Therapeutics, Inc. (:PSTX) has a price-to-earnings ratio of -2.32 and price/earnings-to-growth ratio is 0.04.